Prot #NDX‐3315‐1001: An Open‐label Phase 1b Study Assessing the Safety, Tolerability and Preliminary Diagnostic Performance of a Radioactive Imaging Agent, NDX‐3315, in Healthy Adult Participants and Patients with Eosinophilic Esophagitis

Project: Research project

Project Details

StatusActive
Effective start/end date7/24/23 → 7/24/26

Funding

  • Medpace Clinical Research LLC (Prot #NDX-3315-1001 // Prot #NDX-3315-1001)
  • NexEos Diagnostics, Inc. (Prot #NDX-3315-1001 // Prot #NDX-3315-1001)